REG - Eco Animal Health Gp - Issue of Equity and TVR

ECO Animal HealthAnnouncement

09/10/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241009:nRSI4303Ha&default-theme=true

RNS Number : 4303H  Eco Animal Health Group PLC  09 October 2024

9 October 2024

ECO Animal Health Group plc

("ECO" or the "Company")

 

Issue of Equity and Total Voting Rights

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health
company with a portfolio of marketed veterinary products and a maturing
proprietary R&D pipeline, announces that Christopher Wilks, Chief
Financial Officer, has exercised options over 14,782 ordinary shares of 5
pence each ("Ordinary Shares") at a price of 5 pence per Ordinary Share under
the Company's Deferred Bonus Scheme.  These share options were issued to Mr
Wilks on 24 September 2021 as one-third of his bonus award for the year ended
31 March 2021 and were subject to a three year vesting period in accordance
with the rules of the scheme.

Following this transaction, Christopher Wilks' total interest in the Company
is 173,877 Ordinary Shares, representing approximately 0.26 per cent. of the
Company's issued share capital.

Application has been made to the London Stock Exchange for 14,782 new Ordinary
Shares to be admitted to trading on AIM. Admission and dealings in the new
Ordinary Shares is expected to occur at 8.00 a.m. on 15 October 2024.

The new Ordinary Shares will rank pari passu with the existing Ordinary
Shares.

 

Total Voting Rights

Following Admission, the Company's total issued share capital will consist of
67,759,671 Ordinary Shares with one voting right per share. The Company does
not hold any Ordinary Shares in treasury. The total number of voting rights in
the Company is therefore 67,759,671.

The above figure of 67,759,671 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the Company under
the FCA's Disclosure Guidance and Transparency Rules.

 

-Ends-

For further information please contact:

 ECO Animal Health Group plc                                    020 8447 8899

 David Hallas (CEO)

 Christopher Wilks (CFO)
 Singer Capital Markets (Nominated Adviser & Joint Broker)      020 7496 3000

 Phil Davies

 Sam Butcher
 Investec (Joint Broker)                                        020 7597 5970

 Gary Clarence

 Lydia Zychowska
 Equity Development                                             020 7065 2692

 Hannah Crowe

 Matt Evans
 ICR Consilium (Financial PR)                                   020 3709 5700

 Mary-Jane Elliott                                              ecoanimalhealth@consilium-comms.com

 Jessica Hodgson

 

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing
branded veterinary pharmaceuticals globally, with expertise in antibiotics and
vaccines for pigs and poultry. We have a maturing proprietary R&D
pipeline.

Headquartered in the UK, with global offices including R&D and
manufacturing, we have marketing authorisations in over 70 countries and
employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is
effective against both respiratory and intestinal diseases in pigs and
poultry.

Click here for more information: https://ecoanimalhealth.com
(https://ecoanimalhealth.com)

( )

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         Christopher Wilks

 2    Reason for the notification

 a)   Position/status                                              Chief Financial Officer

 b)   Initial notification /Amendment                              Initial notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         ECO Animal Health Group plc

 b)   LEI                                                          2138009XN9DJ3YP70B55

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 5 pence each

      Identification code                                          GB0032036807

 b)   Nature of the transaction                                    Exercise of options

 c)   Price(s) and volume(s)

                                                                                     Price(s)          Volume(s)
                                                                                     5 pence           14,782

 d)   Aggregated information                                       N/A - Single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      7 October 2024

 f)   Place of the transaction                                     Off Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFSDFMAELSEES